These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 17380217)

  • 1. Type 2 diabetes, cognitive function and dementia: vascular and metabolic determinants.
    van den Berg E; Kessels RP; Kappelle LJ; de Haan EH; Biessels GJ;
    Timely Top Med Cardiovasc Dis; 2007 Feb; 11():E7. PubMed ID: 17380217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type 2 diabetes, cognitive function and dementia: vascular and metabolic determinants.
    van den Berg E; Kessels RP; Kappelle LJ; de Haan EH; Biessels GJ;
    Drugs Today (Barc); 2006 Nov; 42(11):741-54. PubMed ID: 17171193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diabetic encephalopathy: an underexposed complication of diabetes mellitus].
    Brands AM; Henselmans JM; de Haan EH; Biessels GJ
    Ned Tijdschr Geneeskd; 2003 Jan; 147(1):11-4. PubMed ID: 12564291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diabetes mellitus and cognition: is there a link?].
    Barrou Z; Lemaire A; Boddaert J; Verny M
    Psychol Neuropsychiatr Vieil; 2008 Sep; 6(3):189-98. PubMed ID: 18786878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular risk factors and dementia.
    Fillit H; Nash DT; Rundek T; Zuckerman A
    Am J Geriatr Pharmacother; 2008 Jun; 6(2):100-18. PubMed ID: 18675769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive functioning in elderly persons with type 2 diabetes and metabolic syndrome: the Hoorn study.
    van den Berg E; Dekker JM; Nijpels G; Kessels RP; Kappelle LJ; de Haan EH; Heine RJ; Stehouwer CD; Biessels GJ
    Dement Geriatr Cogn Disord; 2008; 26(3):261-9. PubMed ID: 18841011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral dysfunction in type 1 diabetes: effects of insulin, vascular risk factors and blood-glucose levels.
    Brands AM; Kessels RP; de Haan EH; Kappelle LJ; Biessels GJ
    Eur J Pharmacol; 2004 Apr; 490(1-3):159-68. PubMed ID: 15094082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of serum gamma-glutamyltransferase to atherogenic dyslipidemia and glycemic control in type 2 diabetes.
    Zoppini G; Targher G; Trombetta M; Lippi G; Muggeo M
    Obesity (Silver Spring); 2009 Feb; 17(2):370-4. PubMed ID: 19057528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor during hypoglycemia in patients with type 1 diabetes mellitus: relation to cognitive function and renin-angiotensin system activity.
    Kristensen PL; Høi-Hansen T; Boomsma F; Pedersen-Bjergaard U; Thorsteinsson B
    Metabolism; 2009 Oct; 58(10):1430-8. PubMed ID: 19573885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertension and cognitive function in the elderly.
    Cherubini A; Lowenthal DT; Paran E; Mecocci P; Williams LS; Senin U
    Am J Ther; 2007; 14(6):533-54. PubMed ID: 18090879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular cognitive deterioration and stroke.
    Erkinjuntti T
    Cerebrovasc Dis; 2007; 24 Suppl 1():189-94. PubMed ID: 17971655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IANA task force on nutrition and cognitive decline with aging.
    Gillette Guyonnet S; Abellan Van Kan G; Andrieu S; Barberger Gateau P; Berr C; Bonnefoy M; Dartigues JF; de Groot L; Ferry M; Galan P; Hercberg S; Jeandel C; Morris MC; Nourhashemi F; Payette H; Poulain JP; Portet F; Roussel AM; Ritz P; Rolland Y; Vellas B
    J Nutr Health Aging; 2007; 11(2):132-52. PubMed ID: 17435956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactive effect of central obesity and hypertension on cognitive function in older out-patients with Type 2 diabetes.
    Kim E; Cho MH; Cha KR; Park JS; Ahn CW; Oh BH; Kim CH
    Diabet Med; 2008 Dec; 25(12):1440-6. PubMed ID: 19046243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive dysfunction and its clinical and radiological determinants in patients with symptomatic arterial disease and diabetes.
    Tiehuis AM; Mali WP; van Raamt AF; Visseren FL; Biessels GJ; van Zandvoort MJ; Kappelle LJ; van der Graaf Y;
    J Neurol Sci; 2009 Aug; 283(1-2):170-4. PubMed ID: 19268970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gestational diabetes, pregnancy hypertension, and late vascular disease.
    Carpenter MW
    Diabetes Care; 2007 Jul; 30 Suppl 2():S246-50. PubMed ID: 17596480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetic nephropathy in 27,805 children, adolescents, and adults with type 1 diabetes: effect of diabetes duration, A1C, hypertension, dyslipidemia, diabetes onset, and sex.
    Raile K; Galler A; Hofer S; Herbst A; Dunstheimer D; Busch P; Holl RW
    Diabetes Care; 2007 Oct; 30(10):2523-8. PubMed ID: 17630266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current concepts in vascular cognitive impairment and pharmacotherapeutic implications.
    Rojas-Fernandez CH; Moorhouse P
    Ann Pharmacother; 2009 Jul; 43(7):1310-23. PubMed ID: 19584390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperglycaemia as a determinant of cognitive decline in patients with type 1 diabetes.
    Wessels AM; Scheltens P; Barkhof F; Heine RJ
    Eur J Pharmacol; 2008 May; 585(1):88-96. PubMed ID: 18396273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diabetes mellitus and cognitive impairments].
    Tüma I
    Vnitr Lek; 2007 May; 53(5):486-8. PubMed ID: 17642429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cognitive impairments among diabetic patients].
    Talarowska M; Florkowski A; Gałecki P; Orzechowska A; Janiak M; Zboralski K
    Pol Merkur Lekarski; 2008 Oct; 25(148):349-55. PubMed ID: 19145935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.